Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium
about
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Recommendations for Screening ...... d Marrow Transplant Consortium
@en
Recommendations for Screening ...... d Marrow Transplant Consortium
@nl
type
label
Recommendations for Screening ...... d Marrow Transplant Consortium
@en
Recommendations for Screening ...... d Marrow Transplant Consortium
@nl
prefLabel
Recommendations for Screening ...... d Marrow Transplant Consortium
@en
Recommendations for Screening ...... d Marrow Transplant Consortium
@nl
P2093
P2860
P1476
Recommendations for Screening ...... d Marrow Transplant Consortium
@en
P2093
Andrew C Dietz
Andrew R Gennery
Benedicte Neven
Christine Duncan
Elie Haddad
Jennifer Heimall
Jennifer Puck
K Scott Baker
Linda M Griffith
Luigi Notarangelo
P2860
P304
P356
10.1016/J.BBMT.2017.04.026
P577
2017-05-04T00:00:00Z